Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Abbott Laboratories (ABT)

Abbott Laboratories (ABT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 183,675,136
  • Shares Outstanding, K 1,741,657
  • Annual Sales, $ 44,328 M
  • Annual Income, $ 6,524 M
  • EBIT $ 9,735 M
  • EBITDA $ 12,851 M
  • 60-Month Beta 0.74
  • Price/Sales 4.21
  • Price/Cash Flow 15.33
  • Price/Book 3.53

Options Overview Details

View History
  • Implied Volatility 29.71% (-0.76%)
  • Historical Volatility 21.36%
  • IV Percentile 95%
  • IV Rank 49.90%
  • IV High 42.50% on 04/07/25
  • IV Low 16.97% on 08/12/25
  • Expected Move (DTE 4) 2.41 (2.29%)
  • Put/Call Vol Ratio 0.39
  • Today's Volume 4,826
  • Volume Avg (30-Day) 13,031
  • Put/Call OI Ratio 0.99
  • Today's Open Interest 128,914
  • Open Int (30-Day) 168,803
  • Expected Range 102.87 to 107.69

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 28 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate 1.15
  • Number of Estimates 10
  • High Estimate 1.20
  • Low Estimate 1.13
  • Prior Year 1.09
  • Growth Rate Est. (year over year) +5.50%

Price Performance

See More
Period Period Low Period High Performance
1-Month
104.52 +0.08%
on 03/23/26
116.82 -10.45%
on 02/27/26
-10.69 (-9.27%)
since 02/23/26
3-Month
104.52 +0.08%
on 03/23/26
129.46 -19.20%
on 01/06/26
-19.94 (-16.01%)
since 12/23/25
52-Week
104.52 +0.08%
on 03/23/26
139.06 -24.78%
on 06/24/25
-21.74 (-17.20%)
since 03/21/25

Most Recent Stories

More News
Abbott completes acquisition of Exact Sciences

ABBOTT PARK, Ill. , March 23, 2026 /PRNewswire/ -- Abbott (NYSE: ABT) today announced it has completed the acquisition of Exact Sciences, establishing Abbott as a leader in fast-growing cancer screening...

ABT : 104.48 (-0.93%)
Abbott acquisition of Exact Sciences set to close on March 23, 2026

ABBOTT PARK, Ill. , March 20, 2026 /PRNewswire/ -- Abbott (NYSE: ABT) today announced that it expects to close the acquisition of Exact Sciences on Monday, March 23, 2026. The announcement follows...

ABT : 104.48 (-0.93%)
3 High Dividend Growth Kings for Generations of Income That Are Still Rated ‘Buy’

These 3 Dividend Kings combine steady businesses, rising dividends, and solid upside potential for long-term income investors.

ABT : 104.48 (-0.93%)
LOW : 234.28 (+4.30%)
RPM : 96.12 (+3.10%)
This Dividend King With a 54-Year Dividend Streak Is Down 13% YTD. Time to Buy the Dip?

This Dividend King is suddenly on sale. Should you buy the dip?

ABT : 104.48 (-0.93%)
$SPX : 6,587.76 (+1.25%)
Landmark study shows Libre technology helps people with Type 2 diabetes on basal insulin improve glucose management

ABBOTT PARK, Ill. , March 12, 2026 /PRNewswire/ -- Abbott (NYSE: ABT), a global healthcare leader, today announced results from the FreeDM2 randomized controlled trial (RCT) showing that people using...

ABT : 104.48 (-0.93%)
Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks

Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks

ABT : 104.48 (-0.93%)
Abbott and Real Madrid launch nationwide effort to build the next 'Abbott Dream Team'

ABBOTT PARK, Ill. , March 11, 2026 /PRNewswire/ -- Abbott (NYSE: ABT) announced today the launch of the second year of the 'Abbott Dream Team,' encouraging young soccer players aged 18–19 across...

ABT : 104.48 (-0.93%)
2 Profitable Stocks on Our Watchlist and 1 We Avoid

2 Profitable Stocks on Our Watchlist and 1 We Avoid

AMAT : 362.24 (+1.45%)
ABT : 104.48 (-0.93%)
CCL : 25.59 (+6.09%)
2 Reasons to Like ABT and 1 to Stay Skeptical

2 Reasons to Like ABT and 1 to Stay Skeptical

ABT : 104.48 (-0.93%)
Is Medtronic Stock Underperforming the S&P 500?

Medtronic has underperformed the S&P 500 over the past year. However, Wall Street analysts remain moderately optimistic about its prospects.

ABT : 104.48 (-0.93%)
$SPX : 6,587.76 (+1.25%)
MDT : 86.68 (+0.60%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell and ranks in the Top 1% of all short term signal directions.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Abbott Labs discovers, develops, manufactures & sells a diversified line of health care products. Established Pharmaceuticals Division includes branded generics business in the emerging markets. Medical Devices unit includes the diabetes care, vision care & vascular businesses. Diagnostics unit manufactures...

See More

Key Turning Points

3rd Resistance Point 109.42
2nd Resistance Point 108.61
1st Resistance Point 107.03
Last Price 104.48
1st Support Level 104.64
2nd Support Level 103.83
3rd Support Level 102.25

See More

52-Week High 139.06
Fibonacci 61.8% 125.87
Fibonacci 50% 121.79
Fibonacci 38.2% 117.71
Last Price 104.48
52-Week Low 104.52

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.